Dexcom (Nasdaq:DXCM) has issued an update related to a recall for its continuous glucose monitor (CGM) components.

Abbott (NYSE:ABT) today reported Street-beating second-quarter results that included significant growth in its Diabetes ...

(NYSE:JNJ) announced today that the FDA granted priority review to a new drug application (NDA) for its TAR-200.

LifeScan announced that it entered into a restructuring support agreement and, to implement it, filed for chapter 11 bankruptcy.

Sequel built its twiist system on underlying drug delivery technology developed by DEKA R&D. Dean Kamen, co-founder of Sequel ...

Insulet (Nasdaq:PODD) announced that it named Lisa Blair Davis as its new SVP and chief human resources officer.

Breakthrough T1D (formerly JDRF) and Mattel announced a partnership to debut the first Barbie doll with type 1 diabetes (T1D) ...

The medtech giant announced in May that it planned to separate the Diabetes unit into a standalone, publicly traded company.

Diabeloop today announced the commercial availability of its DBLG1 algorithm with the Dana-i insulin pump from Sooil in ...

Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor ...

While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have something different.

Glucotrack (Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.